DMS Blog

Pediatric PET Imaging: A 2020 Perspective

Pediatric PET Imaging: A 2020 Perspective

The world of pediatric imaging was revolutionized a couple of decades ago with the introduction of pediatric PET/CT. This subsequently found wide acceptance in pediatric oncological imaging, among other applications. PET/MRI is a more recent development, approved in pediatric patients

Read More »
The Clinical Impact of Utilizing NETSPOT

The Clinical Impact of Utilizing NETSPOT

NETSPOT (68Ga-Dotatate) is a radioactive diagnostic agent used for PET imaging that is gaining ground among practices. FDA-approved in 2016, NETSPOT is used in imaging to locate somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients. The commercial product

Read More »

PET/CT imaging new tracer guide

The landscape of PET/CT imaging is rapidly changing. Traditionally, physicians have used a sugar based radiopharmaceutical, 18Fluorodeoxyglucose or 18FDG, to perform the majority of PET/CT imaging. Over the past 20 years, this imaging agent was the only option available to many

Read More »
STAY IN THE KNOW

Sign-up to receive monthly imaging news and resources

CONNECT WITH DMS

©2020 DMS Health Technologies